dual NK1 antagonist/SERT inhibitors (Bristol-Myers)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual NK1 antagonist/SERT inhibitors (Bristol-Myers)
Drug Alias Namedual NK1 receptor antagonist and serotonin reuptake transporter inhibitors (Bristol-Myers)BMS-817693
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsSerotonin transporter inhibitorsNeurokinin 1 receptor antagonists
TargetsNeurokinin 1 receptorSerotonin transporter
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A